Literature DB >> 7913503

Sulfasalazine induced seizures and dysphasia.

M E Hill1, C Gordon, R D Situnayake, D A Heath.   

Abstract

We describe the case of a 46-year-old woman with rheumatoid arthritis who developed a severe reaction to sulfasalazine, characterized by dysphasia, seizures, rash and the development of strongly positive pANCA (perinuclear antineutrophil cytoplasmic antibodies). Her condition improved spontaneously upon withdrawal of sulfasalazine. Dysphasia has not been reported as a side effect of sulfasalazine.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7913503

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  4 in total

1.  An unusual cause for collapse in a patient with arthritis.

Authors:  K J Heath; M J Sampson; S A Ridley
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

Review 2.  Topiramate and cognitive impairment: evidence and clinical implications.

Authors:  Marco Mula
Journal:  Ther Adv Drug Saf       Date:  2012-12

3.  Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.

Authors:  L G Quallich; J Greenson; H M Haftel; R J Fontana
Journal:  BMC Gastroenterol       Date:  2001-08-29       Impact factor: 3.067

4.  Reversible global aphasia as a side effect of quetiapine: a case report and literature review.

Authors:  Ching-Fang Chien; Poyin Huang; Sun-Wung Hsieh
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-28       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.